Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Roche and Nurix Therapeutics Partner to Advance BTK Degrader Bexobrutideg
Monday, June 08, 2026Roche has entered into an exclusive licensing and collaboration agreement with Nurix Therapeutics to codevelop and cocommercialise bexobrutideg NX an investigational Brutons Tyrosine Kinase BTK degrader
Stipple Bio Signs Licensing Agreement with Lonza for Precision Oncology ADC Development
Friday, June 05, 2026Stipple Bio has entered a multitarget licensing agreement with Lonza to support the development of nextgeneration antibodydrug conjugate ADC therapies for cancer treatment
Biogen’s Salanersen Granted FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
Friday, June 05, 2026Biogen announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to salanersen for the treatment of spinal muscular atrophy SMA
Chai Discovery Signs Licensing Agreement with Pfizer to Advance AI-Driven Drug Discovery
Friday, June 05, 2026Chai Discovery has entered into a licensing agreement with Pfizer to support the use of artificial intelligence in drug discovery and accelerate the development of new medicines
Alnylam and Inceptive Partner to Accelerate RNAi Drug Discovery Using AI
Thursday, June 04, 2026Alnylam Pharmaceuticals Inc and Inceptive Nucleics Inc have entered into a strategic collaboration aimed at accelerating the discovery and development of RNA interference RNAi therapeutics through the use of artificial intelligence
Massive Bio and Optellum Partner to Improve Clinical Trial Access for Early-Stage Lung Cancer Patients
Thursday, June 04, 2026Massive Bio and Optellum have entered into a collaboration aimed at improving access to clinical trials for patients with earlystage nonsmall cell lung cancer NSCLC The partnership combines Optellums artificial intelligence
Travere Therapeutics Signs Licensing Agreement with Everest Medicines for Civorebrutinib
Wednesday, June 03, 2026Travere Therapeutics has entered into an exclusive licensing and collaboration agreement with Everest Medicines for the development and commercialisation of civorebrutinib EVER an investigational oral Brutons tyrosine kinase
First Foundation Labs Collaborates with Microsoft to Enhance AI-Driven Clinical and Translational Reasoning
Wednesday, June 03, 2026First Foundation Labs FL a life sciences artificial intelligence company established by Luma Group has announced a collaboration with Microsoft to support the development and enterprise deployment of its
Agios secures global rights to develop and commercialise cevidoplenib for rare blood disorders
Tuesday, June 02, 2026Agios Pharmaceuticals has entered into an exclusive global licensing agreement with South Koreabased Oscotec to develop and commercialise cevidoplenib an investigational nextgeneration oral spleen tyrosine kinase SYK inhibitor
Vertex’s biologics application for povetacicept in IgA nephropathy accepted by US FDA
Tuesday, June 02, 2026Vertex Pharmaceuticals has announced that the US Food and Drug Administration FDA has accepted its Biologics License Application BLA for povetacicept an investigational engineered fusion protein being developed for the treatment of adults with immuno...
